GNTA
NASDAQ
$1.58
Genenta Science SpA (GNTA)
Genenta Science SpA, a clinical-stage biotechnology company, is dedicated to the development of hematopoietic stem cell gene therapies for the treatment of solid tumors in Italy. The company is headquartered in Milan, Italy.
Sector:
Healthcare
Industry:
Biotechnology
Target: $6.98 (+341.77%)
Market Cap
$36M
Free Cash Flow Yield
-22.52%
Beta (5Y)
0.64
Price Chart
Valuation
Market Cap$36M
P/B1.64
Profitability
EBITDA-$7.72M
EPS-$0.33
Financial Health
Free Cash Flow Yield-22.52%
Growth & Risk
EPS 5Y CAGR-2.68%
Beta (5Y)0.64
Sharpe Ratio0.14